Picture of Ajanta Pharma logo

AJANTPHARM — Ajanta Pharma News Story

0.000.00%
in flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

India's Ajanta Pharma rises as US FDA completes Dahej facility inspection

** Shares of speciality pharmaceuticals maker Ajanta Pharma
 AJPH.NS  rise as much as 4.49% to 1,528.55 rupees
    ** Co said its formulation facility at Dahej was inspected
by the U.S. FDA from June 19-23, and the regulator did not issue
any Form 483 
    ** A Form FDA 483 is issued to a company's management at the
conclusion of an inspection when an investigator(s) has observed
conditions that in their judgment may constitute violations of
the Food, Drug, and Cosmetic (FD&C) Act and other Acts or
regulations
    ** Share price above 50-day, 100-day and 200-day exponential
moving averages since May 16, suggesting bullish trend
    ** More than 81,000 shares change hands vs 30-day avg of
123,038 shares
    ** Twelve of 13 analysts covering the stock have a "buy" or
"strong buy" rating, while one has "hold"; median PT is 1,520
rupees - Refinitiv data
    ** Ajanta stock up 20.7% YTD, as of last close

    

 (Reporting by Ashish Chandra in Bengaluru)
 ((ashish.chandra@thomsonreuters.com (+91 7982114624))

Recent news on Ajanta Pharma

See all news